Abstract:Abstract Background Resveratrol is a plant secondary metabolite with diverse, potential health-promoting benefits. Due to its nutraceutical merit, bioproduction of resveratrol via microbial engineering has gained increasing attention and provides an alternative to unsustainable chemical synthesis and straight extraction from plants. However, many studies on microbial resveratrol production were implemented with the addition of water-insoluble phenylalanine or tyrosine-based precursors to the medium, limiting in the sustainable development of bioproduction. Results Here we present a novel coculture platform where two distinct metabolic background species were modularly engineered for the combined total and de novo biosynthesis of resveratrol. In this scenario, the upstream Escherichia coli module is capable of excreting p -coumaric acid into the surrounding culture media through constitutive overexpression of codon-optimized tyrosine ammonia lyase from Trichosporon cutaneum ( TAL ), feedback-inhibition-resistant 3-deoxy-d-arabinoheptulosonate-7-phosphate synthase ( aroG fbr ) and chorismate mutase/prephenate dehydrogenase ( tyrA fbr ) in a transcriptional regulator tyrR knockout strain. Next, to enhance the precursor malonyl-CoA supply, an inactivation-resistant version of acetyl-CoA carboxylase ( ACC1 S659A,S1157A ) was introduced into the downstream Saccharomyces cerevisiae module constitutively expressing codon-optimized 4-coumarate-CoA ligase from Arabidopsis thaliana ( 4CL ) and resveratrol synthase from Vitis vinifera ( STS ), and thus further improve the conversion of p -coumaric acid-to-resveratrol. Upon optimization of the initial inoculation ratio of two populations, fermentation temperature, and culture time, this co-culture system yielded 28.5 mg/L resveratrol from glucose in flasks. In further optimization by increasing initial net cells density at a test tube scale, a final resveratrol titer of 36 mg/L was achieved. Conclusions This is first study that demonstrates the use of a synthetic E. coli – S. cerevisiae consortium for de novo resveratrol biosynthesis, which highlights its potential for production of other p -coumaric-acid or resveratrol derived biochemicals.

Heterologous biosynthesis of prenylated resveratrol through multiplex metabolic engineering in Escherichia coli

Heterologous Biosynthesis of Prenylated Resveratrol and Evaluation of Antioxidant Activity

Optimization of Biosynthetical Conditions of Resveratrol with Recombinant Escherichia coli

Efficient de novo synthesis of resveratrol by metabolically engineered Escherichia coli

De novo resveratrol production through modular engineering of an Escherichia coli–Saccharomyces cerevisiae co-culture

Biosynthesis of resveratrol and piceatannol in engineered microbial strains: achievements and perspectives

De Novo Synthesis of Resveratrol from Sucrose by Metabolically Engineered Yarrowia lipolytica

Synthetic Biology-Driven Microbial Production of Resveratrol: Advances and Perspectives

A Computational Metabolic Model for Engineered Production of Resveratrol in Escherichia coli

Biosynthesis of pterostilbene in Escherichia coli from resveratrol on macroporous adsorption resin using a two‐step substrate addition strategy

Remodelling metabolism for high-level resveratrol production in Yarrowia lipolytica

Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol

Coupling the Isopentenol Utilization Pathway and Prenyltransferase for the Biosynthesis of Licoflavanone in Recombinant Escherichia Coli

Biotechnological Advances in Resveratrol Production and its Chemical Diversity

De novo biosynthesis of pterostilbene in an Escherichia coli strain using a new resveratrol O-methyltransferase from Arabidopsis

Improved Linalool Production in Saccharomyces Cerevisiae by Combining Directed Evolution of Linalool Synthase and Overexpression of the Complete Mevalonate Pathway

Engineering the oleaginous yeast Yarrowia lipolytica for high-level resveratrol production

In planta production of the highly potent resveratrol analogue pterostilbene via stilbene synthase and O-methyltransferase co-expression

Engineering of 4-hydroxyphenylacetate-3-hydroxylase from Escherichia coli for efficient biosynthesis of piceatannol

De novo biosynthesis of diverse plant-derived styrylpyrones in Saccharomyces cerevisiae

Reprogramming the metabolism of oleaginous yeast for sustainably biosynthesizing the anticarcinogen precursor germacrene A